PASG

Passage Bio (PASG)

Passage Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PASG

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/23	20:00	GlobeNewswire Inc.	Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference	NASDAQ:PASG	Passage Bio Inc
2024/09/16	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/09/16	20:00	GlobeNewswire Inc.	Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)	NASDAQ:PASG	Passage Bio Inc
2024/09/10	20:52	GlobeNewswire Inc.	Passage Bio Welcomes Tom Kassberg to Board of Directors	NASDAQ:PASG	Passage Bio Inc
2024/09/10	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/09/07	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/08/30	20:00	GlobeNewswire Inc.	Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:PASG	Passage Bio Inc
2024/08/10	06:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:PASG	Passage Bio Inc
2024/08/08	20:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PASG	Passage Bio Inc
2024/08/08	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/08/08	20:00	GlobeNewswire Inc.	Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
2024/08/06	20:00	GlobeNewswire Inc.	Passage Bio to Participate in Upcoming Investor Conferences	NASDAQ:PASG	Passage Bio Inc
2024/08/03	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/08/01	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/08/01	20:00	GlobeNewswire Inc.	Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration	NASDAQ:PASG	Passage Bio Inc
2024/07/16	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/07/16	20:00	GlobeNewswire Inc.	Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients	NASDAQ:PASG	Passage Bio Inc
2024/06/05	20:30	GlobeNewswire Inc.	Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:PASG	Passage Bio Inc
2024/05/24	05:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2024/05/23	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/05/21	21:00	GlobeNewswire Inc.	Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award	NASDAQ:PASG	Passage Bio Inc
2024/05/14	21:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20:00	GlobeNewswire Inc.	Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
2024/04/22	20:00	GlobeNewswire Inc.	Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:PASG	Passage Bio Inc
2024/03/05	21:00	GlobeNewswire Inc.	Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program	NASDAQ:PASG	Passage Bio Inc
2024/03/05	07:22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PASG	Passage Bio Inc
2024/03/05	06:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PASG	Passage Bio Inc
2024/03/04	21:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PASG	Passage Bio Inc